| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.888 | 20.894 | 20.560 | 23.763 | 27.203 | 27.787 | 26.084 | 39.587 | 45.077 | 44.543 |
| Total Income - EUR | 19.888 | 20.894 | 20.560 | 23.763 | 27.203 | 27.977 | 29.010 | 40.434 | 45.100 | 44.543 |
| Total Expenses - EUR | 9.864 | 10.697 | 4.465 | 12.364 | 12.912 | 9.387 | 12.833 | 17.044 | 22.992 | 22.140 |
| Gross Profit/Loss - EUR | 10.024 | 10.197 | 16.095 | 11.399 | 14.291 | 18.590 | 16.177 | 23.390 | 22.108 | 22.403 |
| Net Profit/Loss - EUR | 9.427 | 9.570 | 15.478 | 10.686 | 13.475 | 17.800 | 15.350 | 22.447 | 21.666 | 21.093 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dermamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | -486 | -1.110 | 0 | 30 | 28 | 24.977 | 17.900 | 11.329 | 4.754 | 0 |
| Current Assets | 43.686 | 52.977 | 57.023 | 11.767 | 16.810 | 21.125 | 14.744 | 26.114 | 29.377 | 30.969 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 41.990 | 43.183 | 56.349 | 10.233 | 13.073 | 17.520 | 13.409 | 22.683 | 19.962 | 16.754 |
| Cash | 1.696 | 9.793 | 674 | 1.535 | 3.737 | 3.605 | 1.335 | 3.431 | 9.415 | 14.214 |
| Shareholders Funds | 43.078 | 52.209 | 57.395 | 10.737 | 13.526 | 17.849 | 15.399 | 22.495 | 21.715 | 21.141 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 206 | 252 | 212 | 1.060 | 3.313 | 26.441 | 16.386 | 14.925 | 12.416 | 9.828 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 1.811 | 867 | 23 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermamed Srl